Towards Healthcare
U.S. Genotyping Market
Updated Date: 01 November 2025   |   Report Code: 5160

U.S. Genotyping Market Size, Emerging Opportunities and Competitive Landscape

Projections indicate that, the global U.S. genotyping market will increase from USD 7.33 billion in 2024 to USD 26.53 billion by 2034, experiencing a CAGR of 13.72% over the next 10 years. The increasing importance of genotyping in biotechnology and healthcare is driving the market’s growth.

Last Updated : 01 November 2025 Category: Biotechnology Insight Code: 5160 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

U.S. Genotyping Market Assessment

  • Overview
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Instruments
    • Reagents & Kits
    • Software and Services
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • PCR
    • Capillary Electrophoresis
    • Microarrays
    • Sequencing
    • Mass Spectrometry
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Pharmacogenomics
    • Diagnostics and Personalized Medicine
    • Agricultural Biotechnology
    • Animal Genetics
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Pharmaceutical and Biopharmaceutical Companies
    • Diagnostics and Research Laboratories
    • Academic Institutes
    • Others

Company Profiles

  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GE Healthcare Inc.
  • Eurofins Scientific Inc.
  • Agilent Technologies
  • Danaher Corporation
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.

Conclusion & Recommendations

FAQ's

Answer : There are three types of genotypes: homozygous dominant (PP), homozygous recessive (pp) and heterozygous (Pp).

Answer : Genetic testing of skin, hair, blood, amniotic fluid or other tissues is used for the detection of genotypes.

Answer : Molecular beacons, DNA sequencing, SNP microarrays, mass spectrometry and PCR-based methods.

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar